Lars Rydén
About
In The Last Decade
Lars Rydén
115 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Cardiology and Cardiovascular Medicine 8.6k
- Radiology, Nuclear Medicine and Imaging 2.0k
- Endocrinology, Diabetes and Metabolism 1.9k
- Surgery 1.7k
- Epidemiology 820
Countries citing papers authored by Lars Rydén
This map shows the geographic impact of Lars Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rydén more than expected).
Fields of papers citing papers by Lars Rydén
This network shows the impact of papers produced by Lars Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rydén. The network helps show where Lars Rydén may publish in the future.
Co-authorship network of co-authors of Lars Rydén
This figure shows the co-authorship network connecting the top 25 collaborators of Lars Rydén. A scholar is included among the top collaborators of Lars Rydén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Rydén. Lars Rydén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | Glycosylated haemoglobin predicts mortality in patients with heart failure and unknown diabetes : insights from the Swedish Heart Failure registry (SwedeHF) | 1 |
| 3 | 24 | |
| 4 | Impact of diabetes mellitus on heart failure with reduced ejection fraction : a Swedish registry based analysis | 1 |
| 5 | 1 | |
| 6 | 285 | |
| 7 | 20 | |
| 8 | 3 | |
| 9 | 5 | |
| 10 | Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study breakdown → | 796 |
| 11 | Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction breakdown → | 3778 |
| 12 | Prognostic value of exercise stress testing versus ambulatory electrocardiography after acute myocardial infarction: a 3 year follow-up study. | 4 |
| 13 | 27 | |
| 14 | 0 | |
| 15 | Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial Infarction breakdown → | 676 |
| 16 | Angiotensin - Converting Enzyme-inhibition and Mortality in Heart-failure - Is Enalapril Better Than Captopril | 1 |
| 17 | 15 | |
| 18 | 1 | |
| 19 | 92 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.